Investors / Canada / Lumira Ventures
Lumira Ventures
Venture capital · Toronto, ON, Canada · North America
Lumira Ventures is a North American life sciences venture capital firm that invests in and helps build transformative life sciences companies. It partners with founders and management teams to develop and commercialize therapeutic products and medical devices.
Invests inHealthcare & Biotech
In its own wordslife sciencestherapeuticsmedical devicesbiotechhealthcarecancer
Your fit with Lumira Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsLumira Ventures lists 46 checked portfolio companies on its own site and is named in 11 funding rounds, 1 of them as lead. Its most frequent entry is Series B, 56% of the companies with a known first round. Its largest themes are Healthcare & Biotech (96%), Media & Entertainment (2%) and Education (2%). 58% of its companies are based in United States. It invests most often alongside Hatteras Venture Partners, Angelini Ventures and Amzak Health.
Counts come from funding rounds that name Lumira Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Lumira Ventures' whole history. Rounds on record name 10 companies; its own site lists 46. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 33% |
| Series B | 56% |
| Growth | 11% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 2 | 0 |
| '26 | 8 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 81th | 46 companies |
| Recent activity | 93th | 8 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 93th | 22% of companies confirmed by a round |
| Sector focus | 97th | 96% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Hatteras Venture Partners | 5 |
| Angelini Ventures | 4 |
| Amzak Health | 3 |
| Aperture Venture Partners | 3 |
| CTI Life Sciences Fund | 3 |
| Canaan | 3 |
| Creative Destruction Lab | 3 |
| MaRS IAF | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4393%
- No longer answers00%
- Points to another company37%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 96% | 15% |
| Media & Entertainment | 2% | 4% |
| Education | 2% | 7% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Hatteras Venture Partners
Compare Lumira Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with Lumira Ventures| Date | Company | Stage |
|---|---|---|
| 3 Nov 2026 | Series B | |
| 2 Nov 2026 | Series A | |
| 17 Sept 2026 | Series A | |
| 18 Jun 2026 | Series B Led | |
| 2 Jun 2026 | Series B | |
| 27 Apr 2026 | Series B | |
| 19 Mar 2026 | Round | |
| 7 Jan 2026 | Series B |
Round details for Lumira Ventures
Amounts, full round histories and every co-investor in Lumira Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
46 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Alpha-9 Oncology is a clinical stage radiopharmaceutical company advancing a portfolio of molecules to treat cancer cells | Healthcare & Biotech | Oct 2024Series C+ | Page + round | |
| The company's website appears to be a demonstration of a rich text editor. | Media & EntertainmentEducation | Sept 2026Series A | Page + round | |
| Alveolus Bio develops biotherapeutic delivery systems for the prevention and treatment of chronic lung disease | Healthcare & Biotech | Portfolio page | ||
| AmacaThera develops a hydrogel drug delivery platform for precise and sustained release of therapeutics | Healthcare & Biotech | Portfolio page | ||
| Antiva Biosciences is developing a novel topical therapeutic for the treatment of oncogenic human papillomavirus infections and pre-cancerous cervical lesions | Healthcare & Biotech | Portfolio page | ||
| Aurinia Pharmaceuticals develops treatments for autoimmune diseases, including lupus nephritis. | Healthcare & Biotech | Portfolio page | ||
| Axonis Therapeutics develops medicines targeting neurological disorders | Healthcare & Biotech | Portfolio page | ||
| BardyDx develops and provides ambulatory ECG monitoring solutions | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Biotheryx is advancing a portfolio of first-in-class protein degraders, with an initial focus on validated targets in cancer and inflammatory disease. | Healthcare & Biotech | Portfolio page | ||
| Bright Angel Therapeutics is a pre-clinical stage biotechnology company focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. | Healthcare & Biotech | Portfolio page | ||
| Cadence Neuroscience is developing a platform for personalized neuromodulation to help people achieve seizure freedom | Healthcare & Biotech | Portfolio page | ||
| Cardiac Dimensions develops and offers a treatment for heart failure patients with functional mitral regurgitation | Healthcare & Biotech | Portfolio page | ||
| Congruence Therapeutics is a clinical-stage biotechnology company that discovers and develops small molecule correctors and allosteric modulators to ameliorate disease conditions at the molecular level. | Healthcare & Biotech | Sept 2025Round · 2 rounds | Page + round | |
| Contraline is a company developing investigational male contraceptive products, including a topical gel and a reversible implant. | Healthcare & Biotech | Jun 2026Series B | Page + round | |
| Corvia Medical, Inc. develops a system for improving quality of life and reducing heart failure related symptoms and events in patients with heart failure. | Healthcare & Biotech | Portfolio page | ||
| COUR Pharma develops targeted therapies for autoimmune diseases | Healthcare & Biotech | Jun 2026Series B | Page + round | |
| Cyrano Therapeutics develops therapies for people dealing with long-term loss of smell and taste. | Healthcare & Biotech | Portfolio page | ||
| Damona Pharmaceuticals is developing therapies to reverse cognitive deficits and restore contact between brain cells | Healthcare & Biotech | Portfolio page | ||
| Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company exploring new ways to treat inflammatory and immune-related diseases. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- lumiraventures.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 23 Oct 2024
- Companies checked
- 46
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Lumira Ventures' profile as data
Pull Lumira Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/lumiraventures.com
# also
GET /v1/firms/lumiraventures.com/portfolio
GET /v1/firms/lumiraventures.com/coinvestors
GET /v1/firms/lumiraventures.com/news